Literature DB >> 11179112

Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons.

S Awasthi1, J J Coalson, B A Yoder, E Crouch, R J King.   

Abstract

Surfactant proteins A (SP-A) and D (SP-D) are important in the innate host defense against pathogenic microorganisms. A deficit in these proteins in premature infants, either because of immaturity or as a consequence of superimposed chronic lung disease (CLD), could increase their susceptibility to infection. The study reported here examined infection in CLD in the premature newborn baboon, and correlated it with the amounts of SP-A and SP-D in lung tissue and lavage fluid. Two groups of baboons were delivered prematurely, at 125 d gestational age (g.a.), and differed principally in whether they developed naturally acquired pulmonary infections and sepsis. Group I animals were ventilated with clinically appropriate oxygen for 6 d and 14 d without clinical incident. Group II animals were ventilated for 5 to 71 d, but differed from those in Group I in that most developed pulmonary infection and/or sepsis. In Group I animals, tissue pools of both SP-A and SP-D were equal to or exceeded those in adults, and lavage pools of SP-A increased progressively with the time of ventilation to about 35% of adult levels after 14 d. In contrast, most Group II animals had concentrations of lavage SP-A that were less than 20% of that in adult animals. A low concentration of lavage SP-A correlated with the release of interleukin-8, and with a high "infection index" based on histopathology, microbiologic cultures, and clinical indications of sepsis. Our data suggest that the amounts of SP-A and SP-D in lavage fluid are indicators of the risk of infection in the evolution of neonatal CLD. Deficits in the amount of lavage SP-A, even after 60 d of ventilation, may have inhibited the resolution of infection and thereby contributed to the developing injury among our Group II animals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179112     DOI: 10.1164/ajrccm.163.2.2004168

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

Review 1.  Chronic lung disease in the preterm infant. Lessons learned from animal models.

Authors:  Anne Hilgendorff; Irwin Reiss; Harald Ehrhardt; Oliver Eickelberg; Cristina M Alvira
Journal:  Am J Respir Cell Mol Biol       Date:  2014-02       Impact factor: 6.914

Review 2.  Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins.

Authors:  Frederico Vieira; Johannes W Kung; Faizah Bhatti
Journal:  Ann Anat       Date:  2017-03-27       Impact factor: 2.698

3.  A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells.

Authors:  Shanjana Awasthi; Kevin Brown; Catherine King; Vibhudutta Awasthi; Rajkumar Bondugula
Journal:  J Pharmacol Exp Ther       Date:  2010-12-15       Impact factor: 4.030

4.  Surfactant protein-A and toll-like receptor-4 modulate immune functions of preterm baboon lung dendritic cell precursor cells.

Authors:  Shanjana Awasthi; Rakhesh Madhusoodhanan; Roman Wolf
Journal:  Cell Immunol       Date:  2011-03-04       Impact factor: 4.868

5.  Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.

Authors:  J K van de Wetering; F E J Coenjaerts; A B Vaandrager; L M G van Golde; J J Batenburg
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Enhanced surfactant protein and defensin mRNA levels and reduced viral replication during parainfluenza virus type 3 pneumonia in neonatal lambs.

Authors:  Branka Grubor; Jack M Gallup; David K Meyerholz; Erika C Crouch; Richard B Evans; Kim A Brogden; Howard D Lehmkuhl; Mark R Ackermann
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

7.  Surfactant protein-A limits Ureaplasma-mediated lung inflammation in a murine pneumonia model.

Authors:  Mobolaji E Famuyide; Jeffrey D Hasday; Heather C Carter; Kirsty L Chesko; Ju-Ren He; Rose M Viscardi
Journal:  Pediatr Res       Date:  2009-08       Impact factor: 3.756

Review 8.  Animal models of bronchopulmonary dysplasia. The preterm baboon models.

Authors:  Bradley A Yoder; Jacqueline J Coalson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-03       Impact factor: 5.464

Review 9.  Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem.

Authors:  Raquel Arroyo; Paul S Kingma
Journal:  Respir Res       Date:  2021-05-08

10.  Safety of inhaled ivermectin as a repurposed direct drug for treatment of COVID-19: A preclinical tolerance study.

Authors:  Suzan M Mansour; Rehab N Shamma; Kawkab A Ahmed; Nirmeen A Sabry; Gamal Esmat; Azza A Mahmoud; Amr Maged
Journal:  Int Immunopharmacol       Date:  2021-07-23       Impact factor: 4.932

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.